Rebirth 90: I opened a hospital in Shencheng

Chapter 174 Starting with 3000!
The cost of Zheng Jinhai's operation is the highest since Aihua Clinic opened.

However, after Nie Chen reported this figure, Zheng Jinhai did not fluctuate at all, and even defaulted that 65 was a fair price.

Zhong Lanlan, who was making tea and water, had flickering eyes, raised her eyebrows, and glanced at this middle-aged man who was sitting upright and tall and upright.

Really rich.

"Well, Comrade Wei will go to Shencheng or a hospital in our army for a full-body examination first, and then bring it to the outpatient clinic for scheduling. It is expected that surgery can be arranged next week."

Five o'clock in the afternoon.

"Dr. Nie, this is Manager Li of Xinde Pharmaceutical's biopharmaceutical department, and this is Director Liu of the biopharmaceutical department."

Ye Wanqiu's ward.

Ye Wanqiu calmly and peacefully introduced two bosses of the biopharmaceutical department of Xinde Medical Industry to Nie Chen.

"Hi Doctor Nie, you are really young and promising!"

Manager Li, with gray hair and about 45 years old, took the initiative to stand up beside Ye Wanqiu's hospital bed, and shook hands with Nie Chen, who was sitting opposite Ye Wanqiu.

Manager Li introduced himself: "My name is Li Jianming, and my hometown is in Wanwan. My parents are both scientists in the field of biology. I am relatively unsatisfactory and have not made much achievements in this area, so I partnered with Boss Ye to earn a few dollars. The money of second-hand traffickers."

Nie Chen smiled and held his hand and shook it up and down: "Manager Li is joking, I have heard that Xinde Pharmaceutical's international channel is very wild, and Li Jing deserves the most credit."

Then Director Liu also came over and introduced himself to Nie Chen: "My name is Liu Yuanzhi, Dr. Nie. I heard that our outpatient clinic has developed a formula for a special drug for vascular malformations. This really shocked me."

After exchanging pleasantries.

The two camps have already set up a posture to talk about the negotiation in Ye Wanqiu's ward.

Nie Chen's camp.

In addition to Nie Chen himself, Li Dayong, who also participated in the vascular malformation research group, was present as a group representative.

But he didn't take the initiative to introduce each other to Ye Wanqiu and the department leaders in his company, he just bowed his head silently and took notes.

Except for Nie Chen and Li Dayong.

The legal representatives for the negotiation of Aihua Clinic are Zhou De and Jimmy Chen.

"Miss Ye, Zhoude Law Firm and Aihua Outpatient Clinic have signed a long-term contract. We are human, and reason is reasonable."

Zhou De took the initiative to accuse Ye Wanqiu of his crimes, and then unequivocally sided with Chen Jimi on Nie Chen's side.

Ye Wanqiu's camp.

The technical representatives are Li Jianming and Liu Yuanzhi, the two technical leaders of the department.

He Xiaomin, the project manager who was accompanying Ye Wanqiu in the ward, was not present.

"My name is Liu Xia, and I am the legal representative of the legal department of Xinde Pharmaceutical."

Standing next to Ye Wanqiu was a tall young woman with hair in a bun, gold-rimmed glasses, and office women's clothing that is more popular nowadays. She introduced herself to Nie Chen and Li Dayong.

Then she smiled and saw Zhou De again: "Lawyer Zhou, your business is unexpectedly broad."

Both camps are ready.

Ye Wanqiu was the first to state the conditions she could offer: "Doctor Nie, Xinde Pharmaceutical sent personnel from our research team to intervene in our research team. All the research funds in the early stage and the assembly line factory after production will be paid by us. We want to get A 20-year patent right for this vascular malformation biopharmaceutical.”

"it's out of the question."

Zhou De interrupted the condition proposed by Ye Wanqiu: "The patent right of this biopharmaceutical can only be owned by Dr. Nie Chen from the Aihua Outpatient Clinic. This is not negotiable."

joke.

As early as last week, Nie Chen had given Zhou De and Jimmy Chen a list of various medical devices and biological drugs that needed to be patented in China and Hong Kong Island.

The current negotiation is only to discuss how far this channel of Xinde Pharmaceutical can achieve.

If the requirements of the Aihua Clinic are not met, Nie Chen can withdraw from the negotiation at any time.

That is to say, the final initiative of everything is in the hands of Aihua Clinic Nie Chen.

This is also the reason why Nie Chen has not had much reaction to the olive branch thrown by Ye Wanqiu these days.

"Lawyer Zhou doesn't need to deny this plan too quickly."

Manager Li of Xinde Pharmaceutical, he took a look at Zhou De, and then asked Nie Chen with a smile: "Doctor Nie, if our new drug has a theoretical result, then based on the conditions that Boss Ye just proposed, We are willing to invest an additional 3000 million yuan in the research and experimental production phase of this new drug."

Li Jiaming said that he took out a list from his briefcase, and pushed the list to Nie Chen's desk.

"In terms of theory in clinical trials, there is no problem with our drug."

Nie Chen, who came prepared, took out a clinical trial paper that was printed out in the printer warehouse last night in his briefcase.

The title of this paper is:
"Effect of rapamycin on peritumoral and intratumoral lymphatic vessel formation in melanoma transplanted nude mice"

The whole paper has 25 pages.

The paper introduces in great detail that rapamycin is used in the prognosis of malignant skin and soft tissue tumors.

And using mice implanted with human melanoma cells, a double-blind test was carried out.

When Nie Chen took out this paper.

Professor Li Dayong, who was silently taking notes with his head down, turned up his mouth slightly, revealing a complacent smile.

before coming to negotiate.

Li Dayong has already observed the whole article, and Nie Chen's double-blind test paper on the use of rapamycin in melanoma.

The data techniques and experimental methods inside opened Li Dayong's eyes.

It can be said like this.

Compared with Nie Chen's previous surprise, this paper was also shown to him by Li Dayong. It is a review paper on vascular malformation, high flow rate and low flow rate using images and human body mechanics to judge.

In terms of practical value, it can be said that it exceeds more than a hundred times.

This is an article that clearly and clearly concludes that the rapamycin ointment and rapamycin tablets currently used in the Aihuamen Clinic are targeted specific drugs that are really used in the field of melanoma vascular malformations.

"impossible!"

Li Jianming graduated from the famous Massachusetts Department of Biology in the United States. He is very good at this experimental paper on the experimental method of double-blind testing of new drugs using mice.

At a glance, it can be basically judged whether the data in the paper is falsified, whether it is random, and whether repeated experiments can be carried out.

But this paper.

Obviously, it has proved that rapamycin, a drug that has not yet been marketed.

In terms of clinical practice, it has reached an extremely mature stage of pharmacological experiments!
In biopharmaceuticals, it is impossible for one person to do experiments alone, remain unknown, and then become a blockbuster, reaching such a terrifying level.

Now even Li Jianming, an expert in biopharmaceuticals, has enough contacts to know the main research directions of major laboratories in the world.

At this moment, after seeing this paper, his scalp was also numb.

He knew clearly that rapamycin could only be made from fermentation broth for rapamycin crystallization by using certain soil from Easter Island in the South Pacific as a culture medium.

There is currently only one such rapamycin fermentation broth, and that is Pfizer's laboratory.

And Pfizer is also in the early stages of laboratory trials for this drug.

It is impossible to be like Nie Chen.

It is possible to get such an article, which is extremely mature, and has built a practical paper on the experimental model of double-blind testing with mice.

"Once again, the patent copyright must belong to Nie Chen of Aihua Clinic 100%."

When Ye Wanqiu and Zhenyun whispered to each other, Jimmy Chen gave two dimples of laughter, and reiterated to the legal staff of Ye Wanqiu's camp the bottom line of the negotiation for Nie Chen's camp.

(End of this chapter)